11.01.09
Natraceutical Group, Valencia, Spain, and Naturex, Avignon, France, have formalized the binding contracts for the merger of their ingredient activities. The transaction will be structured by means of the integration of Natraceutical’s Ingredients Division into Naturex. Natraceutical is to hold a stake of 39% in Naturex and become a board member, alongside SGD, the family-controlled holding company of Jacques Dikansky, Naturex’s chairman and CEO, who will remain the reference shareholder in terms of voting rights. The transaction also comprises €38 million for Natraceutical, debt or cash, €10 million of which will not be made effective until the confirmation of both companies’ year-end results.
